Close Menu

Beware of buzzwords when investing in a new technology, says Derek Lowe at In the Pipeline. He makes fun of an announcement released earlier this year by Primegen, saying that they used carbon nanotubes to reprogram stem cells. Though both are hot fields, they're also still very new. "So what are the odds of getting them to work together? Not as good as the odds that someone thought the combination would make a good press release, I'm afraid," he says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.